a30 104p goat polyclonal antichicken iga (Bethyl)
Bethyl is a verified supplier 
93
Structured Review
Bethyl
a30 104p goat polyclonal antichicken iga
A30 104p Goat Polyclonal Antichicken Iga, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 50 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+goat+antichicken+iga/Chicken+IgG+(IgY)-Fc+Fragment+Antibody/pm38029604-29-41-60
Average 93 stars, based on 50 article reviews
A30 104p Goat Polyclonal Antichicken Iga, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 50 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+goat+antichicken+iga/Chicken+IgG+(IgY)-Fc+Fragment+Antibody/pm38029604-29-41-60
Average 93 stars, based on 50 article reviews
a30 104p goat polyclonal antichicken iga - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
other:Article Title: The effects of arginine and branched-chain amino acid supplementation to reduced-protein diet on intestinal health, cecal short-chain fatty acid profiles, and immune response in broiler chickens challenged with Eimeria spp. Article Snippet: HRP-conjugated polyclonal goat antichicken IgA (Bethyl Laboratories, Montgomery, TX) was diluted 1:100,000 with 5% nonfat dry milk in the wash buffer and added to the plates at 100 mL/well. Article Title: Rapamycin, a specific inhibitor of the target of rapamycin complex 1, disrupts intestinal barrier integrity in broiler chicks. Article Snippet: To uncover the molecular mechanisms underlying the intestinal barrier integrity, this study determined whether the rapamycin (RAPA)-sensitive target of rapamycin complex 1 (TORC1) pathway was involved in this process.. Three groups of 4-day-old male chicks were randomly subjected to one of the following treatments for 6 days: high-dose RAPA [a specific inhibitor of TORC1; an intraperitoneal injection of 1.0 mg/kg body weight (BW), once daily at 09:00 hours], low-dose RAPA (0.4 mg/kg BW) and RAPA vehicle (control).. Results showed that the RAPA treatment increased mortality, while decreasing villus height (p < 0.01), claudin 1 expression, content of immunoglobulin A (IgA), extent of TORC1 phosphorylation (p < 0.05), ratio of villus height to crypt depth (p < 0.01), and population of IgA-positive B cells in intestinal mucosa, particularly for the jejunum. |